CompletedPhase 4

Effect of Pretreatment of Lignocaine Versus Midazolam in Prevention of Etomidate Induced Myoclonus.

224 participantsStarted 2015-01-01

Plain-language summary

This study is a randomized control trial and it was conducted to compare the effectiveness of pretreatment with lignocaine versus midazolam on the frequency of myoclonus associated with etomidate induction. This was conducted in Holy Family Hospital Rawalpindi in a period of 6 months.

Who can participate

Age range20 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ASA-I / ASA-II * any gender \>20-45 years * undergoing elective surgical procedure. Exclusion Criteria: * Patient who refused * those with any neurological or psychiatric disorders * morbid obesity * drug allergies * pregnant patients

What they're measuring

Occurrence and Frequency of Myoclonus

Timeframe: Immediately after giving etomidate dose.

Occurrence and Frequency of Myoclonus

Timeframe: 20 seconds after giving etomidate dose.

Occurrence and Frequency of Myoclonus

Timeframe: 40 seonds after giving etomidate dose.

Occurrence and Frequency of Myoclonus

Timeframe: 60 seconds after giving etomidate dose.

Trial details

NCT IDNCT04921046

SponsorRawalpindi Medical College

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-06-30

View on ClinicalTrials.gov More Myoclonic Jerk trials